CAPE CANAVERAL, Fla., Aug. 21 /PRNewswire-USNewswire/ -- NASA will hold a briefing at 1 p.m. EDT, Sunday, Aug. 23, to discuss new science experiments using the International Space Station's unique research environment. The briefing will originate from NASA's Kennedy Space Center in Florida and will be broadcast live on NASA Television.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO )
Media are invited to e-mail questions in advance or during the briefing to:
Briefing participants will attempt to answer as many of the submitted questions as possible.
Space shuttle Discovery's STS-128 mission marks the start of the transition from assembling the space station to using it for continuous scientific research as a national and multinational laboratory. Assembly and maintenance activities have dominated the astronaut work time. But as completion of the orbiting laboratory nears, additional facilities and the crew to operate them will enable an increase in time devoted to research.
The briefing participants include:
- Mark Uhran, assistant associate administrator for space station, NASA Headquarters in Washington
- Julie Robinson, International Space Station program scientist, NASA's Johnson Space Center in Houston
- Jeanne Becker, chief science officer, Astrogenetix in Austin, Texas
- Martin Zell, head of the space station utilization department at the European Space Agency
For NASA TV streaming video, downlink and schedule information, visit:
For more information about space station science, visit:
Related biology technology :1
. Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available2
. The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics3
. Frost & Sullivans Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells4
. CIRM Completes Briefing Visit to Stemedica Cell Technologies5
. Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference6
. VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 167
. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 38
. REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO9
. Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing10
. Hepatitis B Foundation and AAPCHO Sponsor Congressional Briefing on Zero Tolerance for Hepatitis B11
. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing